Capital International Ltd. CA trimmed its position in Corteva, Inc. (NYSE:CTVA – Free Report) by 40.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 133,101 shares of the company’s stock after selling 89,923 shares during the quarter. Capital International Ltd. CA’s holdings in Corteva were worth $8,922,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Drummond Knight Asset Management Pty Ltd purchased a new stake in shares of Corteva in the 4th quarter worth $25,713,000. Alberta Investment Management Corp purchased a new stake in shares of Corteva in the 3rd quarter worth $5,018,000. Avior Wealth Management LLC lifted its holdings in shares of Corteva by 464.7% in the 4th quarter. Avior Wealth Management LLC now owns 32,901 shares of the company’s stock worth $2,205,000 after buying an additional 27,075 shares during the period. HighTower Advisors LLC lifted its holdings in shares of Corteva by 8.6% in the 3rd quarter. HighTower Advisors LLC now owns 182,643 shares of the company’s stock worth $12,352,000 after buying an additional 14,436 shares during the period. Finally, Arbejdsmarkedets Tillaegspension purchased a new stake in shares of Corteva in the 4th quarter worth $23,679,000. 81.54% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several research analysts have recently commented on CTVA shares. Jefferies Financial Group boosted their price target on Corteva from $95.00 to $97.00 in a research report on Thursday, May 7th. Wall Street Zen lowered Corteva from a “buy” rating to a “hold” rating in a research report on Saturday, February 7th. BNP Paribas Exane boosted their price target on Corteva from $74.00 to $77.00 in a research report on Wednesday, May 6th. Deutsche Bank Aktiengesellschaft boosted their price target on Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. Finally, Berenberg Bank boosted their price target on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. Fourteen investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $88.67.
Corteva Trading Down 0.5%
CTVA opened at $77.06 on Friday. The firm has a market cap of $51.54 billion, a price-to-earnings ratio of 45.33, a PEG ratio of 2.36 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $85.63. The stock has a fifty day moving average price of $81.17 and a 200-day moving average price of $74.94.
Corteva (NYSE:CTVA – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period in the prior year, the company posted $1.13 EPS. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.
Corteva Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be paid a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 42.35%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
